Archean Chemical Industries logo

Archean Chemical Industries MD, chairman, board of directors and AGM

NSE: ACIBSE: 543657Chemicals & PetrochemicalsSmall Cap

Last close ₹478.45up ₹17.80 (3.86%)BSE ₹479.65

Share price at the NSE close on 23 Oct 2026. Previous close ₹460.65.

52-week range of traded prices to 23 Oct 2026
₹445.60Low, 22 Oct 2026₹676.00High, 31 Oct 2025
Market cap
₹5,907 Cr674th largest listed
P/E
Owners' profit not stated
P/B
3.1
Dividend yield
0.52%
ROCE
5.6%
Debt to equity
0.24
Volume, NSE
6,17,23453.9% delivered

Archean Chemical Industries board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonPADMA CHANDRASEKARAN
  • Company Secretary and Compliance OfficerVIJAYARAGHAVAN NE

7 directors3 independent2 executive2 non-executive

  • PADMA CHANDRASEKARAN · ChairpersonIndependent · joined Nov 2019 · reappointed Nov 2024 · 83 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • PENDURTHI RANJITExecutive · joined Nov 2018 · reappointed Jan 2026 · 1 listed board · 1 committee seat
  • RAMPRAVEEN SWAMINATHANExecutive · joined Jan 2026 · 2 listed boards · 1 as independent · 1 committee seat
  • SUBRAHMANYAM MEENAKSHISUNDARAMNon-executive · joined Mar 2010 · reappointed Jun 2025 · 1 listed board · 2 committee seats, 1 as chair
  • KANDHERI MUNASWAMY MOHANDASSIndependent · joined Dec 2021 · reappointed Jun 2026 · 58 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • CHITTOOR GHATAMBU SETHURAMIndependent · joined Dec 2021 · reappointed Jun 2026 · 58 months as independent · 2 listed boards · 2 as independent · 2 committee seats
  • PENDURTHI RAVINon-executive · joined Jan 2022 · reappointed Jun 2024 · 1 listed board

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 30 Jul 20267 of 7 present3 independent · 79 days in between
    • 11 May 20267 of 7 present3 independent
  • Audit Committee

    Chair KANDHERI MUNASWAMY MOHANDASS

    SUBRAHMANYAM MEENAKSHISUNDARAM, PADMA CHANDRASEKARAN

    • 30 Jul 20263 of 3 present2 independent · 79 days in between
    • 11 May 20263 of 3 present2 independent
  • Nomination and remuneration committee

    Chair KANDHERI MUNASWAMY MOHANDASS

    PADMA CHANDRASEKARAN, SUBRAHMANYAM MEENAKSHISUNDARAM

    • 30 Jul 20263 of 3 present2 independent · 79 days in between
    • 11 May 20263 of 3 present2 independent
  • Stakeholders Relationship Committee

    Chair SUBRAHMANYAM MEENAKSHISUNDARAM

    CHITTOOR GHATAMBU SETHURAM, PENDURTHI RANJIT

    No meeting listed in the filing.

  • Risk Management Committee

    Chair SUBRAHMANYAM MEENAKSHISUNDARAM

    CHITTOOR GHATAMBU SETHURAM, PENDURTHI RANJIT, NATARAJAN RAMAMURTHY

    No meeting listed in the filing.

  • Corporate Social Responsibility Committee

    Chair SUBRAHMANYAM MEENAKSHISUNDARAM

    PADMA CHANDRASEKARAN, PENDURTHI RAVI

    • 11 May 20263 of 3 present1 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • PKF Sridhar & Santhanam LLPPeer-review certificate valid to Oct 2028
1 earlier auditor
  • PKP SRIDHAR & SANTHANAM LLPNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Archean Chemical Industries AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Archean Chemical Industries dividend history

Annual general meeting, 12 Jun 2026

66,203 shareholders on the register on 5 Jun 2026; present: 1 promoter and 39 others; votes counted by V. Sudarsan Babu / V. Sudarsan Babu & Associates.The company's voting result (opens in a new tab)

  1. TO CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS, AUDITORS THEREON.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

  2. TO DECLARE FINAL DIVIDEND ON THE EQUITY SHARES OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

  3. TO CONSIDER AND APPOINT A DIRECTOR IN PLACE OF MR. RAVI PENDURTHI (DIN: 02334379), WHO RETIRES BY ROTATION AND BEING ELIGIBLE, HAS OFFERED HIMSELF FOR RE-APPOINTMENT.
    OrdinaryPromoters have an interest in it
    79.81% for20.19% against

    Against: promoters 0.00% · institutions 60.01% · other public 0.20%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

  4. TO CONSIDER AND REAPPOINT M/S. PKF SRIDHAR & SANTHANAM LLP, CHARTERED ACCOUNTANTS, (FIRM REGISTRATION NUMBER: 003990S/S200018) AS STATUTORY AUDITORS OF THE COMPANY AND FIX THEIR REMUNERATION.
    Ordinary
    99.84% for0.16% against

    Against: promoters 0.00% · institutions 0.48% · other public 0.00%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

  5. TO APPROVE THE CONTINUATION OF DIRECTORSHIP OF MR. KANDHERI MUNUSWAMY MOHANDASS (DIN: 00707839) AS AN INDEPENDENT DIRECTOR OF THE COMPANY UPON ATTAINING THE AGE OF 75 YEARS.
    Special
    98.44% for1.56% against

    Against: promoters 0.00% · institutions 4.65% · other public 0.00%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

  6. TO RE-APPOINT MR. KANDHERI MUNUSWAMY MOHANDASS (DIN: 00707839) AS NON-EXECUTIVE INDEPENDENT DIRECTOR.
    Special
    98.37% for1.63% against

    Against: promoters 0.00% · institutions 4.83% · other public 0.00%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

  7. TO RE-APPOINT MR. CHITTOOR GHATAMBU SETHURAM (DIN: 01081951) AS NON-EXECUTIVE INDEPENDENT DIRECTOR.
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.08% · other public 0.00%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

  8. TO CONSIDER & APPROVE THE RATIFICATION OF REMUNERATION TO THE COST AUDITOR FOR THE FY 2026-27.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 80.68% · promoters 100.00% · institutions 74.42% · other public 1.09%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 12 Mar 2026, 3 resolutions

68,459 shareholders on the register on 6 Feb 2026; votes counted by V. Sudarsan Babu / V. Sudarsan Babu & Associates.The company's voting result (opens in a new tab)

  1. To consider and approve designating Mr. P. Ranjit (DIN: 01952929) as Executive Vice Chairman (Whole-Time Director)
    OrdinaryPromoters have an interest in it
    78.60% for21.40% against

    Against: promoters 0.00% · institutions 61.53% · other public 0.43%

    Turnout: all 78.19% · promoters 95.33% · institutions 74.06% · other public 0.66%

  2. To consider and approve the appointment of Mr. Rampraveen Swaminathan (DIN: 01300682) as Director
    Ordinary
    98.30% for1.70% against

    Against: promoters 0.00% · institutions 4.89% · other public 0.43%

    Turnout: all 78.19% · promoters 95.33% · institutions 74.06% · other public 0.66%

  3. To consider and approve the appointment of Mr. Rampraveen Swaminathan (DIN: 01300682) as Managing Director
    Ordinary
    96.54% for3.46% against

    Against: promoters 0.00% · institutions 9.94% · other public 0.43%

    Turnout: all 78.19% · promoters 95.33% · institutions 74.06% · other public 0.66%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 2 Jun 2025, 5 resolutions

79,583 shareholders on the register on 26 May 2025; present: 2 promoters and 31 others; votes counted by Sudarshan Babu / M/s. V. Sudarshan Babu & Associates.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2025, together with the reports of the Board of Directors, Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.37%

    Turnout: all 79.95% · promoters 100.00% · institutions 74.78% · other public 0.02%

  2. To declare final dividend on the Equity Shares of the Company for the Financial Year ended March 31, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.37%

    Turnout: all 79.95% · promoters 100.00% · institutions 74.78% · other public 0.02%

  3. To consider and appoint a Director in place of Mr. S Meenakshisundaram (DIN: 01176085), who retires by rotation and being eligible, has offered himself for re-appointment.
    Ordinary
    99.30% for0.70% against

    Against: promoters 0.00% · institutions 2.10% · other public 3.47%

    Turnout: all 79.95% · promoters 100.00% · institutions 74.78% · other public 0.02%

  4. To consider and approve the Appointment of Secretarial Auditors M/s. HVS & Associates, (Firm Registration No. P2016TN048300) Practicing Company Secretaries for a period of five consecutive years i.e. from financial 2025-26 to financial year 2029-2030.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.47%

    Turnout: all 79.95% · promoters 100.00% · institutions 74.78% · other public 0.02%

  5. To consider & approve the ratification of remuneration to the Cost Auditor for the FY 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.47%

    Turnout: all 79.95% · promoters 100.00% · institutions 74.78% · other public 0.02%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Jun 2024, 7 resolutions

Present: 2 promoters and 38 others.The company's voting result (opens in a new tab)

  1. To consider and approve standalone and consolidated Financial Statements of the Company for the year ended 31st March 2024, including the audited Balance Sheet as on 31st March 2024, the Statement of Profit and Loss and Cash Flow Statement of the Company, the reports of the Board of Directors and Auditors Report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 74.17% · promoters 100.00% · institutions 61.82% · other public 1.06%

  2. To consider and approve a dividend of Re. 1.00 per share (50%) for the year ended March 31, 2024, on the paid-up capital consisting of 12,33,96,969 equity shares, as recommended by the Board
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 74.17% · promoters 100.00% · institutions 61.82% · other public 1.06%

  3. To appoint a director in place of Mr. P Ravi (DIN - 02334379) who retires by rotation and being eligible, offers himself for re-appointment
    Ordinary
    99.80% for0.20% against

    Against: promoters 0.00% · institutions 0.73% · other public 0.00%

    Turnout: all 74.17% · promoters 100.00% · institutions 61.82% · other public 1.06%

  4. To ratify the remuneration payable to the Cost Auditor for the financial year 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 74.17% · promoters 100.00% · institutions 61.82% · other public 1.06%

  5. To Reappoint Mrs. Padma Chandrasekaran as Independent Director of the Company for a further period of 5 years from 13th November 2024 to 12th November 2029
    Special
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.40% · other public 0.00%

    Turnout: all 74.17% · promoters 100.00% · institutions 61.82% · other public 1.06%

  6. To Ratify the “ARCHEAN CHEMICAL- EMPLOYEES STOCK OPTION PLAN, 2022” (ESOP 2022)
    Special
    83.98% for16.02% against

    Against: promoters 0.00% · institutions 57.73% · other public 0.15%

    Turnout: all 74.17% · promoters 100.00% · institutions 61.82% · other public 1.06%

  7. Payment of Commission to Directors other than Managing Director or Whole-time Director
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.01%

    Turnout: all 74.17% · promoters 100.00% · institutions 61.82% · other public 1.06%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 15 Nov 2023, 1 resolution

The company's voting result (opens in a new tab)

  1. Approval of remuneration to Mr. S Meenakshisundaram (DIN: 01176085) Non-Executive Director under Section 197 of the Companies Act 2013 & Regulation 17 (6) (ca) SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015MoreLess
    Special
    97.41% for2.59% against

    Against: promoters 0.00% · institutions 8.55% · other public 0.00%

    Turnout: all 82.21% · promoters 100.00% · institutions 75.13% · other public 27.89%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 26 Jul 2023, 5 resolutions

Present: 2 promoters and 33 others.The company's voting result (opens in a new tab)

  1. 1 - To consider and approve standalone and consolidated Financial Statements of the Company for the year ended 31st March 2023, including the audited Balance Sheet as at 31st March 2023, the Statement of Profit and Loss and Cash Flow Statement of the Company, the reports of the Board of Directors and Auditors Report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.37% · promoters 100.00% · institutions 78.87% · other public 47.24%

  2. 2 - To consider and approve a dividend of Rs. 2.50 per share (125%) for the year ended March 31, 2023, on the paid-up capital consisting of 12,30,52,989 equity shares, as recommended by the Board.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.37% · promoters 100.00% · institutions 78.87% · other public 47.24%

  3. 3 - To appoint a Director in place of Mr. S Meenakshisundaram, (DIN - 01176085) who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.13% for0.87% against

    Against: promoters 0.00% · institutions 2.77% · other public 0.00%

    Turnout: all 86.37% · promoters 100.00% · institutions 78.87% · other public 47.24%

  4. 4 - To ratify the remuneration payable to the Cost Auditor for the financial year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.37% · promoters 100.00% · institutions 78.87% · other public 47.24%

  5. 5 - To reappoint Mr. P Ranjit as Managing Director of the Company for a further period of 5 years from 27th November 2023 to 26th November 2028.
    SpecialPromoters have an interest in it
    92.90% for7.10% against

    Against: promoters 0.00% · institutions 22.69% · other public 0.00%

    Turnout: all 86.34% · promoters 100.00% · institutions 78.79% · other public 47.24%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 9 Jul 2023, 1 resolution

The company's voting result (opens in a new tab)

  1. Adoption of new set of Articles of Association of the Company
    Special
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.19% · other public 1.69%

    Turnout: all 72.51% · promoters 100.00% · institutions 53.30% · other public 0.15%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 26 Mar 2023, 1 resolution

The company's voting result (opens in a new tab)

  1. To ratify the ''ARCHEAN CHEMICAL-EMPLOYEE STOCK OPTION PLAN 2022
    Special
    88.33% for11.67% against

    Against: promoters 0.00% · institutions 46.29% · other public 0.01%

    Turnout: all 76.61% · promoters 100.00% · institutions 53.91% · other public 34.91%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 12 Jun 2026, 11 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • TO CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS, AUDITORS THEREON.MoreLess
    11 for0 against
  • TO DECLARE FINAL DIVIDEND ON THE EQUITY SHARES OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026.
    11 for0 against
  • TO CONSIDER AND APPOINT A DIRECTOR IN PLACE OF MR. RAVI PENDURTHI (DIN: 02334379), WHO RETIRES BY ROTATION AND BEING ELIGIBLE, HAS OFFERED HIMSELF FOR RE-APPOINTMENT.
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, ICICI Prudential Mutual Fund, Mahindra Manulife Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, WhiteOak Capital Mutual Fund
    • Angel One Mutual Fund, Nippon India Mutual FundGovernance Concern: Low attendance at Board meetings and no justification for leave of absence.
    • Bandhan Mutual Fund, Groww Mutual FundCompliant with law. No issue identified on merit of appointee. Governance Concern: Low attendance at Board meetings and no justification for leave of absence
    • ICICI Prudential Mutual FundRavi Pendurthi, is the promoter of Archean Chemicals Industries Limited & partner at promoter entity which owns Archean Chemical i.e Chemikas Speciality LLP. He has been on the board since July 2022. He has attended three out of seven (43%) board meetings held in FY26 and eleven out of nineteen (57%) board meetings held over last three years which indicates he is not able to devote sufficient time towards the Company. Given the attendance is low despite being the promoter & non independent director, the AMC had voted against the resolution.
    • Mahindra Manulife Mutual FundRavi Pendurthi, 54, is promoter of Archean Chemicals Industries Limited. He is partner at Chemikas Speciality LLP, a promoter entity. He has been on the board since 08 July 2022. He has attended three out of seven (43%) board meetings held in FY26 and eleven out of nineteen (57%) board meetings held over last three years. We expect directors to attend all board meetings during the year and have an attendance threshold of 75% of the board meetings over the last three years. Given this, we do not support the resolution.
    • Mirae Asset Mutual FundAs per advisory recommendation (passive holding). Attendance is less than 50% in board meetings
    • Motilal Oswal Mutual FundLow attendance at board meetings.
    • WhiteOak Capital Mutual FundRavi Pendurthi, 54, is promoter of Archean Chemicals Industries Limited. He has attended three out of seven (43%) board meetings held in FY26 and eleven out of nineteen (57%) board meetings held over last three years. Given his low attendance of the board meetings over the last three years, we do not support the resolution.
    2 for9 against
  • TO CONSIDER AND REAPPOINT M/S. PKF SRIDHAR & SANTHANAM LLP, CHARTERED ACCOUNTANTS, (FIRM REGISTRATION NUMBER: 003990S/S200018) AS STATUTORY AUDITORS OF THE COMPANY AND FIX THEIR REMUNERATION.
    11 for0 against
  • TO APPROVE THE CONTINUATION OF DIRECTORSHIP OF MR. KANDHERI MUNUSWAMY MOHANDASS (DIN: 00707839) AS AN INDEPENDENT DIRECTOR OF THE COMPANY UPON ATTAINING THE AGE OF 75 YEARS.
    Against Angel One Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund
    • Angel One Mutual FundGovernance Concern: Director is accountable as Nomination & Remuneration Committee member,since, Board is non-compliant with respect to retirement by rotation.
    • Groww Mutual FundCompliant with law. No concern w.r.t. merits of the Director. Governance Concern: Director is accountable as NRC member, since, Board is non-compliant u/s 152 of the Companies Act, 2013
    • Motilal Oswal Mutual FundRole as NRC Chairman /member in Board responsible for noncompliance w.r.t. retirement by rotation
    • Nippon India Mutual FundGovernance Concern: Director is accountable as NRC member, since, Board is non-compliant u/s 152 of the Companies Act, 2013
    7 for4 against
  • TO RE-APPOINT MR. KANDHERI MUNUSWAMY MOHANDASS (DIN: 00707839) AS NON-EXECUTIVE INDEPENDENT DIRECTOR.
    Against Angel One Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund
    • Angel One Mutual FundGovernance Concern: Director is accountable as Nomination & Remuneration Committee member,since, Board is non-compliant with respect to retirement by rotation.
    • Groww Mutual FundCompliant with law. No concern w.r.t. merits of the Director. Governance Concern: Director is accountable as NRC member, since, Board is non-compliant u/s 152 of the Companies Act, 2013
    • Motilal Oswal Mutual FundRole as NRC Chairman /member in Board responsible for noncompliance w.r.t. retirement by rotation
    • Nippon India Mutual FundGovernance Concern: Director is accountable as NRC member, since, Board is non-compliant u/s 152 of the Companies Act, 2013
    6 for4 against
  • TO RE-APPOINT MR. CHITTOOR GHATAMBU SETHURAM (DIN: 01081951) AS NON-EXECUTIVE INDEPENDENT DIRECTOR.
    11 for0 against
  • TO CONSIDER & APPROVE THE RATIFICATION OF REMUNERATION TO THE COST AUDITOR FOR THE FY 2026-27.
    11 for0 against
1 proposal not matched to one resolution
  • To re-appoint Mr. Kandheri Munuswamy Mohandass (DIN: 00707839), as a Non-Executive Independent Director of the Company, not liable to retire by rotation, to hold office for a second term of five (5) consecutive years commencing from December 06, 2026 up to December 05, 2031 (both days inclusive), based on the recommendation of the Nomination and Remuneration Committee and approval of the Board of Directors of the Company.MoreLess
    1 for0 against

Mutual fund votes, meeting of 12 Mar 2026, 11 fund houses

  • To consider and approve designating Mr. P. Ranjit (DIN: 01952929) as Executive Vice Chairman (Whole-Time Director)
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, ICICI Prudential Mutual Fund, Mahindra Manulife Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, WhiteOak Capital Mutual Fund
    • Angel One Mutual FundGovernance concern: No absolute cap on variable pay.
    • Bandhan Mutual FundP. Ranjit, 51, is the promoter and was previously the Managing Director of the company. He is now being appointed as Executive Vice Chairperson designated as Whole-time Director. As Managing Director, P. Ranjit was paid a remuneration of Rs. 203.0 mn in FY25. Shareholders must engage with the company to understand why he was paid commission of Rs. 126.7 mn in FY24 and FY25, despite a fall in revenues and net profits. We estimate his annual remuneration at Rs. 208.0 mn, which is high for the size of the business and not in line with peers. Further, his remuneration terms include a commission component for which no absolute cap, and his terms include uncapped reimbursement of medical expenses and boarding and lodging (including for his spouse and support staff during business trips), which we do not support. Thus, we do not support the resolution.
    • Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. No concern on the merit of the appointee. Governance concern: The Company has not disclosed or put an absolute cap on the Commission proposed. Remuneration payable to Executive Directors should be subject to clearly defined limits in both relative and absolute terms to ensure transparency and alignment with best governance practices. In the absence of an explicit absolute ceiling on the commission payable, the structure may allow for the payment of substantial commission amounts.
    • ICICI Prudential Mutual FundP. Ranjit is the promoter and was previously the Managing Director of the company. He is now being appointed as Executive Vice Chairperson designated as Whole-time Director. As Managing Director, P. Ranjit was paid a remuneration of Rs. 20.3 crs in FY25 vs PBT of Rs. 224 crs. His annual remuneration at ~Rs. 20 crs is high for the size of the business and not in line with peers. Further, his remuneration terms include a commission component for which no absolute cap. Thus, we do not support the resolution.
    • Mahindra Manulife Mutual FundP. Ranjit, 51, is the promoter and was previously the Managing Director of the company. He is now being appointed as Executive Vice Chairperson designated as Whole-time Director. As Managing Director, P. Ranjit was paid a remuneration of Rs. 203.0 mn in FY25. We note he was paid commission of Rs. 126.7 mn in FY24 and FY25, despite a fall in revenues and net profits. We estimate his annual remuneration at Rs. 208.0 mn, which is high for the size of the business and not in line with peers. Thus, we do not support the resolution.
    • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)
    • Nippon India Mutual FundGovernance & Transparency Concern: The Company has not disclosed or put an absolute cap on the Commission proposed. Remuneration payable to Executive Directors should be subject to clearly defined limits in both relative and absolute terms.
    • WhiteOak Capital Mutual FundP. Ranjit, 51, is the promoter and was previously the Managing Director of the company. We estimate his annual remuneration at Rs. 208.0 mn, which is high for the size of the business and not in line with peers. We do not support the resolution.
    2 for9 against
  • To consider and approve the appointment of Mr. Rampraveen Swaminathan (DIN: 01300682) as Director
    Against Angel One Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund
    • Angel One Mutual FundGovernance concern: Appointment as non-retiring Director is adding to Non-Compliance with requirement of retirement of Directors by rotation.Transparency concern: No disclosure about the future ESOP grant.
    • Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. No concern on the merit of the appointee. Governance concern: The appointment of Mr. Rampraveen Swaminathan as a non-retiring director would result in the composition of the Board becoming non-compliant under Section 152 of the Companies Act, 2013. Transparency concern: The Company has not disclosed the number of options proposed to be granted, nor has it prescribed an upper limit on the potential ESOP grants that may be made to Mr. Rampraveen Swaminathan in the future. In the absence of such disclosure, shareholders are unable to meaningfully assess the potential economic benefit that may accrue to him pursuant to the future ESOP grant.
    • Nippon India Mutual FundGovernance Concern: The appointment of Mr. Rampraveen Swaminathan as a non-retiring director would render the Board non-compliant with Section 152 of the Companies Act, 2013. Transparency concern: The absence of disclosure on the number and upper limit of ESOP grants to Mr. Rampraveen Swaminathan prevents shareholders from meaningfully assessing his potential economic benefit.
    7 for4 against
  • To consider and approve the appointment of Mr. Rampraveen Swaminathan (DIN: 01300682) as Managing Director
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, ICICI Prudential Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, WhiteOak Capital Mutual Fund
    • Angel One Mutual FundGovernance concern: Appointment as non-retiring Director is adding to Non-Compliance with requirement of retirement of Directors by rotation.Transparency concern: No disclosure about the future ESOP grant.
    • Bandhan Mutual FundRampraveen Swaminathan, 51, is the former Managing Director & CEO of Mahindra Logistics from 2019 to 2025. The company proposes to appoint him as Managing Director for five years from 22 January 2026. There is no clarity on the quantum of ESOPs he is entitled to receive during his tenure, as a result, we are unable to estimate his proposed remuneration. While we support Rampraveen Swaminathan’s appointment as Managing Director, we do not support the resolution because of his open-ended remuneration structure
    • Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. No concern on the merit of the appointee. Governance concern: The appointment of Mr. Rampraveen Swaminathan as a non-retiring director would result in the composition of the Board becoming non-compliant under Section 152 of the Companies Act, 2013. Transparency concern: The Company has not disclosed the number of options proposed to be granted, nor has it prescribed an upper limit on the potential ESOP grants that may be made to Mr. Rampraveen Swaminathan in the future. In the absence of such disclosure, shareholders are unable to meaningfully assess the potential economic benefit that may accrue to him pursuant to the future ESOP grant.
    • ICICI Prudential Mutual FundThe company proposes to appoint him as Managing Director for five years from 22 January 2026. There is no clarity on the quantum of ESOPs he is entitled to receive during his tenure, as a result, it is not possible to estimate his proposed remuneration. While we support Rampraveen Swaminathan’s appointment as Managing Director, we do not support the resolution because of his open-ended remuneration structure.
    • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)
    • Nippon India Mutual FundGovernance Concern: The appointment of Mr. Rampraveen Swaminathan as a non-retiring director would render the Board non-compliant with Section 152 of the Companies Act, 2013. Transparency concern: The absence of disclosure on the number and upper limit of ESOP grants to Mr. Rampraveen Swaminathan prevents shareholders from meaningfully assessing his potential economic benefit.
    • WhiteOak Capital Mutual FundRampraveen Swaminathan, 51, is the former Managing Director & CEO of Mahindra Logistics from 2019 to 2025. We are unable to estimate his proposed remuneration. While we support Rampraveen Swaminathan’s appointment as Managing Director, we do not support the resolution because of his open-ended remuneration structure.
    3 for8 against
6 earlier meetings

Mutual fund votes, meeting of 2 Jun 2025, 12 fund houses

  • To consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2025, together with the reports of the Board of Directors, Auditors thereon.MoreLess
    12 for0 against
  • To declare final dividend on the Equity Shares of the Company for the Financial Year ended March 31, 2025.
    12 for0 against
  • To consider and appoint a Director in place of Mr. S Meenakshisundaram (DIN: 01176085), who retires by rotation and being eligible, has offered himself for re-appointment.
    12 for0 against
  • To consider and approve the Appointment of Secretarial Auditors M/s. HVS & Associates, (Firm Registration No. P2016TN048300) Practicing Company Secretaries for a period of five consecutive years i.e. from financial 2025-26 to financial year 2029-2030.MoreLess
    12 for0 against
  • To consider & approve the ratification of remuneration to the Cost Auditor for the FY 2025-26
    12 for0 against

Mutual fund votes, meeting of 28 Jun 2024, 11 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To consider and approve standalone and consolidated Financial Statements of the Company for the year ended 31st March 2024, including the audited Balance Sheet as on 31st March 2024, the Statement of Profit and Loss and Cash Flow Statement of the Company, the reports of the Board of Directors and Auditors Report thereon.MoreLess
    11 for0 against
  • To consider and approve a dividend of Re. 1.00 per share (50%) for the year ended March 31, 2024, on the paid-up capital consisting of 12,33,96,969 equity shares, as recommended by the Board
    10 for0 against
  • To appoint a director in place of Mr. P Ravi (DIN - 02334379) who retires by rotation and being eligible, offers himself for re-appointment
    11 for0 against
  • To ratify the remuneration payable to the Cost Auditor for the financial year 2024-25
    10 for0 against
  • To Reappoint Mrs. Padma Chandrasekaran as Independent Director of the Company for a further period of 5 years from 13th November 2024 to 12th November 2029
    11 for0 against
  • To Ratify the “ARCHEAN CHEMICAL- EMPLOYEES STOCK OPTION PLAN, 2022” (ESOP 2022)
    Against Bandhan Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Nippon India Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual FundNon-compliant with SEBI (SBEB & SE) Regulations, 2021: Exercise Price and Exercise period not disclosed. Governance Concern: Potential excessive benefits per employee.
    • DSP Mutual FundThe shareholders approved the pre-IPO ESOP scheme at the March 2023 postal ballot. The company had sought approval from National Stock Exchange of India Limited and BSE Limited for listing of 12,90,926 equity shares (post exercise of options). While National Stock Exchange of India Limited and BSE Limited granted approval for listing of 491,400 shares (pre-IPO ESOP grant), they advised the company to again seek shareholders’ approval for the remainder of 799,526 options. The dilution for the ESOP 2022 scheme will be 0.74% of the extended capital base (including options granted but not exercised). The exercise price per option shall be determined by the Nomination and Remuneration committee (NRC). All the options granted pre-listing were at an exercise price of Rs. 2.0. If granted at face value, it represents a discount of 99.67% on the current market price (Rs. 609.0 as on 7 June 2024). We do not favour ESOP schemes where options are granted at a significant discount (of more than 20%) to market price or where there is no clarity on the performance metrics for vesting. ESOPs are ‘pay at risk’ options that employees accept at the time of grant, which is protected if the ESOPs are issued at significant discount to the market price. If the stock options are granted at a significant discount, there is no alignment between the interests of investors and those of employees. We do not support the resolution.
    • Edelweiss Mutual FundWill lead to dilution of shares
    • HDFC Mutual FundESOPs are being granted at a significant discount to market price
    • ICICI Prudential Mutual FundThe Company has indicated that the exercise price shall not be less than the face value, however, it has not disclosed any price or indicative pricing formula and also provided discretion to the Board to determine the Exercise Price. The Company should provide more certain disclosures regarding Maximum number of options issued to individual employees to arrive at a value that is reflective of the Company’s intent. Hence, the AMC voted against the said resolution.
    • Nippon India Mutual FundInadequate Disclosure
    4 for7 against
  • Payment of Commission to Directors other than Managing Director or Whole-time Director
    Against Edelweiss Mutual Fund
    • Edelweiss Mutual FundPrefered Fixed renumeration for non executive directors
    10 for1 against
2 proposals not matched to one resolution
  • Ratification of remuneration of Rs. 1,10,000/- and re-imbursement of out -of- pocket expenses excluding applicable Tax payable to Mr. G Sundaresan, (Membership No. 11733) Cost Accountant, Chennai, for conducting cost audit of the Company for the financial year 2024 - 25.MoreLess
    1 for0 against
  • To declare dividend of Re. 1/- (50%) on Equity Shares of the Company for the financial year ended 31st March 2024.
    1 for0 against

Mutual fund votes, meeting of 15 Nov 2023, 8 fund houses

  • Approval of remuneration to Mr. S Meenakshisundaram (DIN: 01176085) Non-Executive Director under Section 197 of the Companies Act 2013 & Regulation 17 (6) (ca) SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015MoreLess
    Against Kotak Mahindra Mutual Fund, Nippon India Mutual Fund
    • Kotak Mahindra Mutual FundMr. S Meenakshisundaram, 69, is currently Non- Executive Director at Archean Chemical Ltd. He has over four decades of experience in finance. Though no conern has been identified with his time and commitment towards the company, we are voting against on basis on remuneration. The Company got listed in November 2022 and 2,45,700 options were granted under the ESOP 2022 plan. The difference between fair value and exercise price of ESOPs granted has been recognized in the share options outstanding account. The fair value of options as on the date of the grant is 407 and the exercise price is 2. Hence, the perquisite value per option is 405 and the total perquisite value of options granted to Mr. S Meenakshisundaram is ~ 9.95 crore. The Company should have disclosed the exact cost to the Company on account of the said ESOPs in the explanatory statement. No compelling justification for granting ESOPs to NEDs and that too at face value. Hence voting "AGAINST".
    • Nippon India Mutual FundInadequate disclosure
    6 for2 against

Mutual fund votes, meeting of 26 Jul 2023, 7 fund houses

  • 1 - To consider and approve standalone and consolidated Financial Statements of the Company for the year ended 31st March 2023, including the audited Balance Sheet as at 31st March 2023, the Statement of Profit and Loss and Cash Flow Statement of the Company, the reports of the Board of Directors and Auditors Report thereon.MoreLess
    7 for0 against
  • 2 - To consider and approve a dividend of Rs. 2.50 per share (125%) for the year ended March 31, 2023, on the paid-up capital consisting of 12,30,52,989 equity shares, as recommended by the Board.
    7 for0 against
  • 3 - To appoint a Director in place of Mr. S Meenakshisundaram, (DIN - 01176085) who retires by rotation and being eligible, offers himself for re-appointment.
    7 for0 against
  • 4 - To ratify the remuneration payable to the Cost Auditor for the financial year 2023-24.
    7 for0 against
  • 5 - To reappoint Mr. P Ranjit as Managing Director of the Company for a further period of 5 years from 27th November 2023 to 26th November 2028.
    Against HDFC Mutual Fund, ICICI Prudential Mutual Fund, Mahindra Manulife Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund
    • HDFC Mutual FundThe proposed remuneration is high considering the size and complexity of the business
    • ICICI Prudential Mutual FundThe remuneration of Mr. P Ranjit, Managing Director and Promoter of Archean Chemical Industries for FY2023 aggregated to Rs. 246.7 million, which was higher i.e. 4.8% of consolidated PBT and 34.4% of employee benefit expense. His remuneration is high for the Company’s size and is not comparable to peers. The terms entitle him for remuneration of upto 4.5% of net profits without any absolute cap. The company must cap his remuneration in absolute terms. Given there is no absolute cap on the remuneration, the AMC has voted against this resolution.
    • Mahindra Manulife Mutual FundHis FY23 pay aggregated Rs. 246.7 mn, which was high at 4.8% of consolidated PBT and 34.4% of employee benefit expense. His remuneration is high for the company’s size and is not comparable to peers. The company must define performance metrics that determine his variable pay. While we support his reappointment, we are unable to support the resolution given his high compensation.
    • Motilal Oswal Mutual FundCompliant with law. No concern on merit of appointee. Governance concern: Holding position of Executive Chairman & No absolute cap on variable pay.
    • Nippon India Mutual FundNo absolute cap on variable pay
    2 for5 against

Mutual fund votes, meeting of 9 Jul 2023, 7 fund houses

  • Adoption of new set of Articles of Association of the Company
    7 for0 against

Mutual fund votes, meeting of 26 Mar 2023, 5 fund houses

  • To ratify the ''ARCHEAN CHEMICAL-EMPLOYEE STOCK OPTION PLAN 2022
    Against HDFC Mutual Fund, Kotak Mahindra Mutual Fund, Nippon India Mutual Fund
    • HDFC Mutual FundThere is lack of disclosure/clarity on the pricing formula/exercise price at which the ESOP will be granted
    • Kotak Mahindra Mutual FundNon-compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 exercise price not disclosed. No absolute cap on maximum option given to a single employee. The company has only clarified that exercise price and maximum allotment will be decided by the Company s Nomination and Remuneration Committee.
    • Nippon India Mutual FundInadequate disclosure
    2 for3 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Sep 2026.

  • Tax disputeSales Tax and Gujarat VAT Joint Commissioner Rajkot FY 2015-16Since 27 Apr 2022
    Appeal is under progress
  • Tax disputeSales Tax and Gujarat VAT Joint Commissioner Rajkot FY 2016-17Since 23 Aug 2021
    Appeal is under progress
  • Tax disputeSales Tax and Gujarat VAT Joint Commissioner Rajkot FY 2017-18Since 23 Aug 2021
    Appeal is under progress
  • Tax disputeGoods and Service tax (GST) Tamil Nadu FY 2019-20Since 18 Mar 2024
    Appeal is under progress
  • Tax disputeIncome Tax FY 2016-17Since 29 Jun 2026
    Appeal is under progress
    At the filing before: Penalty levied under section 270A(8) for under reported of Income. We preferred an Appeal against this order with CIT(A) NFAC on 07.07.2026.

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.